Humana Q3 2021 Earnings Report
Key Takeaways
Humana Inc. reported strong third-quarter results, with GAAP earnings per diluted common share of $11.84 and adjusted earnings per share of $4.83. The company revised its full-year 2021 EPS guidance to approximately $23.67 on a GAAP basis, or approximately $20.50 on an Adjusted basis.
Humana reported 3Q21 earnings per diluted common share of $11.84 on a GAAP basis, $4.83 on an Adjusted basis.
The company revises FY 2021 EPS guidance to approximately $23.67 on a GAAP basis, or approximately $20.50 on an Adjusted basis.
Humana achieved 97 percent, or 4.8 million of the company's Medicare Advantage members currently enrolled in 4-Star and above contracts for 2022.
The company updates FY 2021 expected individual Medicare Advantage membership growth to 450,000 members, reflecting year-over-year growth of 11 percent.
Humana
Humana
Humana Revenue by Segment
Forward Guidance
Humana is revising its GAAP EPS guidance range for the year ending December 31, 2021 (FY 2021) to approximately $23.67 from the previous range of $24.97 to $25.47. Humana is also revising its FY 2021 Adjusted EPS guidance to approximately $20.50 from the previous guidance range of $21.25 to $21.75.
Revenue & Expenses
Visualization of income flow from segment revenue to net income